section name header

Combination

Phase I

norgestimate 0.18 mg + ethinyl estradiol 25 mcg


Phase II

norgestimate 0.215 mg + ethinyl estradiol 25 mcg


Phase III

norgestimate 0.25 mg + ethinyl estradiol 25 mcg